Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Norway

European Research Council grant · Running

StarFreeze Vital sperm selection for assisted reproduction in severe male infertility conditions

Coordinator
Universitetet I Tromsoe - Norges Arktiske Universitet, Norway
Runs
1 October 2026 to 31 March 2028
Status
Running
EU funding
€150k
Total cost
—
Partners
3 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101335369

What the project is doing

In the project's own words, from its summary on CORDIS.

StarFreeze targets a painful and unresolved bottleneck in assisted reproduction: finding and recovering rare vital sperm in samples where sperm are immotile and visually resemble dead cells. These difficult cases occur in severe male-factor infertility, are highly demanding for embryologists, and often require time-consuming manual procedures with limited throughput and imperfect reliability. The project seeks to translate frontier research from my ERC into a practical route toward objective, scalable selection of vital immotile sperm for challenging infertility conditions.

The project will concentrate on the most important early questions for translation: whether the underlying concept can be engineered into a robust prototype pathway, whether its core functions can be performed with sufficient precision and compatibility, and whether the resulting innovation can be credibly positioned from intellectual property, regulatory, end-user, and market perspectives. If successful, StarFreeze could unlock significant value in the global infertility treatment market by addressing a high-need, high-cost segment where workflows remain manual, slow, difficult to scale, and often place a burden on public healthcare systems.

By the end of the project, StarFreeze will establish whether this high-risk, high-gain concept can define a new category of fertility technology and form the basis for the next translational step toward clinical and commercial deployment.

Topics

Who is involved

OrganisationCityCountryRole
Universitetet I Tromsoe - Norges Arktiske UniversitetTromsoNorwayCoordinator
Norinnova ASTromsoNorwayThird party
Universitetssykehuset Nord-Norge HfTromsoNorwayAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI